MORSE Team

MORSE Consulting summary of CADTH update. On July 31, 2019 CADTH released its Pharmaceutical Reviews Update – Issue 9 and MORSE…

Posted by MORSE Team

pCPA Closing More Negotiations Without Agreements

August 6, 2019

pan-Canadian Pharmaceutical Alliance (pCPA): July 2019 Trends and Insights The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the status of brand negotiations…

Posted by MORSE Team

Number of Active Negotiations (49) at Highest Level Since November 2018

July 7, 2019

pan-Canadian Pharmaceutical Alliance (pCPA): June 2019 Trends and Insights The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the status of brand negotiations…

Posted by MORSE Team

The pCPA Initiates Negotiations for a Second “Group” of Oncology Biosimilars

June 18, 2019

pan-Canadian Pharmaceutical Alliance (pCPA): May 2019 Trends and Insights The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the status of brand negotiations…

Posted by MORSE Team

April 2019 pCPA Update: The pCPA has completed over 250 negotiations

May 14, 2019

pan-Canadian Pharmaceutical Alliance (pCPA): April 2019 Negotiation Status Update The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the status of brand negotiations…

Posted by MORSE Team

March 2019 pCPA Update: Two negotiations initiated prior to completion of CADTH process

April 8, 2019

pan-Canadian Pharmaceutical Alliance (pCPA): March 2019 Negotiation Status Update The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the status of brand negotiations…

Posted by MORSE Team

pCPA Trends and Insights – Two Biosimilars Initiated Negotiations and Two Multi-Indication Negotiations were Completed

March 15, 2019

pan-Canadian Pharmaceutical Alliance (pCPA): February 2019 Negotiation Status Update The pan-Canadian Pharmaceutical Alliance Office (pCPAO) has issued the status of brand…

Posted by MORSE Team

MORSE Consulting Releases its 2018 pCPA Year in Review Infographic

March 7, 2019

MORSE Consulting is pleased to release its 2018 pCPA Year in Review infographic. The purpose of this resource is to help market…

Posted by MORSE Team

Summary of PMPRB Webinar on Meds Entry Watch, 2017

February 27, 2019

MORSE Consulting has prepared a summary of the key highlights from the Patented Medicines Prices Review Board’s (PMPRB) recent webinar on the…

Posted by MORSE Team

A Healthcare-focused Analysis of British Columbia’s 2019 Budget

February 22, 2019

MORSE Consulting is pleased to release a new report by Stephen Filbey of WestPAR Consulting, one of its strategic partners, entitled A…

Posted by MORSE Team

pCPA Negotiation Status Update January 2019 – Two Oncology Negotiations Closed without LOI

February 14, 2019

pan-Canadian Pharmaceutical Alliance (pCPA): January 2019 Negotiation Status Update The pan-Canadian Pharmaceutical Alliance Office (pCPAO) has issued the status of brand…

Posted by MORSE Team

Spotlight on the Atlantic Provinces: pCPA Letter of Intent Conversion and Time-to-Listing Analysis

January 24, 2019

MORSE Consulting is pleased to release a new report entitled Spotlight on the Atlantic Provinces: pCPA Letter of Intent Conversion and Time-to-Listing…

Posted by MORSE Team

pCPA Process Timelines Highlights – A Year-in-Review Primer

January 15, 2019

pan-Canadian Pharmaceutical Alliance (pCPA): December 2018 Negotiation Status Update The pan-Canadian Pharmaceutical Alliance Office (pCPAO) issued the status of brand negotiations…

Posted by MORSE Team

Season’s Greetings from MORSE Consulting

December 20, 2018

We wish you a safe, peaceful, and enjoyable holiday season and the very best for 2019. —

Posted by MORSE Team

pCPA Complete its Most Active Month by Adjudicating 15 Files in November

December 20, 2018

pan-Canadian Pharmaceutical Alliance (pCPA): November 2018 Negotiation Status Update The pan-Canadian Pharmaceutical Alliance Office (pCPAO) has issued the status of brand…

Posted by MORSE Team

International Experience with Pharmaceutical Managed Entry Agreements

December 13, 2018

Toronto, December 13, 2018 – Neil Grubert and MORSE Consulting are pleased to announce the release of a new report entitled Pharmaceutical…

Posted by MORSE Team

BC Pharmacare Now Transitioning Patients on Copaxone® to GLATECT™

November 29, 2018

On November 27, 2018 the BC Ministry of Health changed coverage of glatiramer products, GLATECT™ and COPAXONE®, which demonstrates a shift from…

Posted by MORSE Team

Number of Active pCPA Negotiations at an All-Time High and Continues to Climb

November 19, 2018

pan-Canadian Pharmaceutical Alliance (pCPA): October 2018 Negotiation Status Update The pan-Canadian Pharmaceutical Alliance Office (pCPAO) has issued the status of brand…

Posted by MORSE Team

Significant Developments in Canadian Drugs for Rare Disease Policy

November 14, 2018

Summary of Expensive Drugs for Rare Diseases (EDRD) Working Group Webinar Signals Decoded: Stakeholder consultation is underway on a supplemental…

Posted by MORSE Team

6 MIN READ

Presidents’ Roundtable – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

November 8, 2018

Panel 6: Presidents’ Roundtable Panel Description: This session brought together general managers from three innovative pharmaceutical companies operating in Canada to…

Posted by MORSE Team

13 MIN READ

Summary of the CADTH Drug Portfolio Information Session Nov. 2018

November 7, 2018

Summary of CADTH Drug Portfolio Information Session Date: Thursday, November 1, 2018 Time: 1:30 pm to 4:00 pm Presenters: Brian O’Rourke,…

Posted by MORSE Team

12 MIN READ

Patient Support Programs – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

November 1, 2018

Panel 5: Patient Support Programs Panel Description: This session will help participants develop a better understanding of why PSPs are well-suited…

Posted by MORSE Team

9 MIN READ

pCPA Panel – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

October 25, 2018

Panel 4: Pan-Canadian Pharmaceutical Alliance Panel Description: This panel will focus on recent events surrounding the pCPA and how public payers…

Posted by MORSE Team

HTA Panel – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

October 18, 2018

Panel 3: Health Technology Assessment Panel Description: Canada’s centralized HTA agency, CADTH, has recently released a new 3-year strategic plan that…

Posted by MORSE Team

8 MIN READ

Summary of the HC-HTA Alignment Webinar Sept. 2018

October 17, 2018

Aligned Reviews Between Health Canada (HC) and Health Technology Assessment Organizations (HTAs) Date: September 26th, 2018 Time: 10:00 AM - 11:30…

Posted by MORSE Team

PE Panel – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

October 11, 2018

Panel 2: Pharmacoeconomics Panel Description: This panel will focus on the growing influence of pharmacoeconomics (PE) in the Canadian reimbursement process.…

Posted by MORSE Team

11 MIN READ

pCPA Reducing Time to Initiate Negotiations

October 10, 2018

pan-Canadian Pharmaceutical Alliance (pCPA): September 2018 Negotiation Status Update The pan-Canadian Pharmaceutical Alliance Office (pCPAO) has issued the status of brand…

Posted by MORSE Team

6 MIN READ

Anita Gadhok Strengthens MORSE Consulting’s Payer Expertise

October 9, 2018

Toronto, October 9, 2018 –MORSE Consulting is pleased to announce the addition of Anita Gadhok as Senior Consultant. With more than 20…

Posted by MORSE Team

PMPRB Panel – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

October 2, 2018

PMPRB Panel On Tuesday, June 19, 2018, the Canadian Association for Healthcare Reimbursement (CAHR) held the Market Access 201 conference in Toronto.…

Posted by MORSE Team

12 MIN READ

Summary of pCPA’s Webinar on Biologics Policy Directions & pCPA Negotiations

September 27, 2018

pCPA Biosimilars/Biologics Policy Directions Webinar On Tuesday September 25, 2018 the pan-Canadian Pharmaceutical Alliance Office (pCPAO) hosted a one-hour webinar for…

Posted by MORSE Team

Summary of PMPRB Webinar on Compass Rx, 4th Edition 2016/2017

September 21, 2018

MORSE Consulting has prepared a brief summary of the key highlights from the Patented Medicine Prices Review Board's (PMPRB) recent webinar on…

Posted by MORSE Team

pCPA Monthly Trends & Insights – August 31, 2018

September 14, 2018

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The August 31, 2018 update has been issued by the pan-Canadian Pharmaceutical Alliance. The…

Posted by MORSE Team

CADTH & INESSS Pilot Project: Joint Engagement with Clinical Specialists

September 14, 2018

On September 13th, 2018, the Canadian Agency for Drugs and Technologies in Health (CADTH) issued details on a new CADTH and Institut…

Posted by MORSE Team

pCPA Monthly Trends & Insights – July 31, 2018

August 13, 2018

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The July 31, 2018 update has been issued by the pan-Canadian Pharmaceutical Alliance. The…

Posted by MORSE Team

pCPA Monthly Trends & Insights – June 30, 2018

July 17, 2018

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The June 30, 2018 update has been issued by the pan-Canadian Pharmaceutical Alliance. The…

Posted by MORSE Team

pCPA Brand Process Guidelines Webinar

July 3, 2018

pCPA Brand Process Guidelines Webinar On Friday, June 22nd, 2018 the pan-Canadian Pharmaceutical Alliance Office (pCPAO) hosted an industry consultation session…

Posted by MORSE Team

pCPA Monthly Trends & Insights – May 31, 2018

June 15, 2018

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The May 31, 2018 update has been issued by the pan-Canadian Pharmaceutical Alliance. The…

Posted by MORSE Team

pCPA Monthly Trends & Insights – April 2018

May 7, 2018

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The April 30, 2018 update has been issued by the pan-Canadian Pharmaceutical Alliance. The…

Posted by MORSE Team

pCPA Update as of March 31, 2018

April 12, 2018

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The March 31, 2018 update has been issued by the pan-Canadian Pharmaceutical Alliance Office…

Posted by MORSE Team

MORSE Consulting Proudly Participates at the 2018 CADTH Symposium

April 12, 2018

MORSE Consulting’s Managing Principal, Sherry O’Quinn, and Principal Consultant, Brad Alyward, are proud to participate in this year’s CADTH Symposium taking place…

Posted by MORSE Team

pCPA Monthly Trends & Insights – February 2018

March 13, 2018

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The February 28, 2018 update has been issued by the pan-Canadian Pharmaceutical Alliance Office…

Posted by MORSE Team

A Comparison of Proposed INESSS and Current CADTH Evaluation Fees

March 6, 2018

A Comparison of Proposed INESSS and Current CADTH Evaluation Fees On February 21, 2018, the Quebec government released draft regulations (Gazette…

Posted by MORSE Team

pCPA Monthly Trends & Insights – January 2018

February 12, 2018

pCPA Monthly Trends & Insights – January 2018 The January 31, 2018 update has been issued by the pan-Canadian Pharmaceutical Alliance…

Posted by MORSE Team

Cornerstone Research Group and MORSE Consulting form a Strategic Partnership

February 7, 2018

Toronto, February 7, 2018: Cornerstone Research Group and MORSE Consulting are pleased to announce the creation of a strategic partnership between…

Posted by MORSE Team

pCPA: 2017 Year in Review

January 31, 2018

MORSE Consulting has prepared a Year in Review infographic to highlight some key metrics surrounding the pCPA’s activities in 2017. This analysis…

Posted by MORSE Team

pCPA Update as of December 31, 2017

January 16, 2018

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The December 31, 2017 update has been issued by the pan-Canadian Pharmaceutical Alliance Office…

Posted by MORSE Team

Happy Holidays from MORSE Consulting

December 21, 2017

As we enter the holiday season and the close of MORSE’s first year of operation, we wish to express our heartfelt gratitude…

Posted by MORSE Team

pCPA Update as of November 30, 2017

December 8, 2017

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The November 30, 2017 update has been issued by the pan-Canadian Pharmaceutical Alliance Office…

Posted by MORSE Team

pCPA Update as of October 31, 2017

November 8, 2017

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The October 31, 2017 update has been issued by the pan-Canadian Pharmaceutical Alliance Office…

Posted by MORSE Team

Lorraine Boyle Joins MORSE Consulting as Senior Advisor

October 16, 2017

Toronto, October 16, 2017 – Sherry O’Quinn and Arvind Mani are very pleased to announce that Lorraine Boyle has joined the MORSE team…

Posted by MORSE Team

pCPA Update as of September 30, 2017

October 7, 2017

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The September 30, 2017 update has been issued by the pan-Canadian Pharmaceutical Alliance Office…

Posted by MORSE Team

Introducing MORSE LINKS – A Comprehensive List of Pharmaceutical Market Access Resources

September 26, 2017

Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting Inc. is pleased to introduce MORSE LINKS, a new feature on our website. MORSE…

Posted by MORSE Team

pCPA Update as of August 31, 2017

September 11, 2017

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The August 31, 2017 update has been issued by the pan-Canadian Pharmaceutical Alliance Office…

Posted by MORSE Team

MORSE Consulting Welcomes WestPAR as a New Strategic Partner

September 11, 2017

Toronto, September 11, 2017 – Arvind Mani and Sherry O’Quinn are pleased to announce our newest strategic partner: Stephen Filbey of WestPAR –…

Posted by MORSE Team

Upcoming Market Access Events / Conferences – September 2017

August 30, 2017

The MORSE KEY: Upcoming Events and Conferences There are a number of conferences/events/deadlines that individuals in market access may be interested…

Posted by MORSE Team

pCPA Panel – CAHR Market Access 201: Parallel or Intersecting Paths – Future of Public and Private Reimbursement in Canada

August 17, 2017

pCPA Panel On Tuesday, June 13, 2017, the Canadian Association for Healthcare Reimbursement (CAHR) held the Market Access 201 conference in…

Posted by MORSE Team

Quebec Panel – CAHR Market Access 201: Parallel or Intersecting Paths – Future of Public and Private Reimbursement in Canada

August 15, 2017

Quebec Panel On Tuesday, June 13, 2017, the Canadian Association for Healthcare Reimbursement (CAHR) held the Market Access 201 conference in…

Posted by MORSE Team

8 MIN READ

Health Technology Assessment Panel – CAHR Market Access 201: Parallel or Intersecting Paths – Future of Public and Private Reimbursement in Canada

August 10, 2017

Health Technology Assessment Panel On Tuesday, June 13, 2017, the Canadian Association for Healthcare Reimbursement (CAHR) held the Market Access 201…

Posted by MORSE Team

pCPA Update as of July 31, 2017

August 9, 2017

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The latest update as of July 31, 2017 has been issued by the pan-Canadian…

Posted by MORSE Team

Biosimilar Panel – CAHR Market Access 201: Parallel or Intersecting Paths – Future of Public and Private Reimbursement in Canada

August 8, 2017

Biosimilar Panel On Tuesday, June 13, 2017, the Canadian Association for Healthcare Reimbursement (CAHR) held the Market Access 201 conference in…

Posted by MORSE Team

pCPA Update as of June 30, 2017

July 10, 2017

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Updates The latest update as of June 30, 2017 has been issued by the pan-Canadian…

Posted by MORSE Team

MORSE Consulting Welcomes a New Strategic Partner

July 5, 2017

Toronto, July 5, 2017 – Arvind Mani and Sherry O’Quinn are pleased to announce our newest strategic partnership with Dominika Dabrowski of DKDA Consulting. Dominika has 12+ years…

Posted by MORSE Team

Upcoming Market Access Events / Conferences – July 2017

June 29, 2017

The MORSE KEY: Upcoming Events and Conferences There a number of conferences and events that individuals in market access may be…

Posted by MORSE Team

PMPRB Panel – CAHR Market Access 201: Parallel or Intersecting Paths – Future of Public and Private Reimbursement in Canada

June 27, 2017

Topic 1: PMPRB Panel On Tuesday, June 13, 2017, the Canadian Association for Healthcare Reimbursement (CAHR) held its Market Access 201…

Posted by MORSE Team

7 MIN READ

Introducing the MORSE WIRE – Live market access news and trends at your finger tips

June 22, 2017

Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting Inc. is pleased to introduce MORSE WIRE, a new feature on our website. MORSE…

Posted by MORSE Team

Changes in the Private Payer Environment: Great-West Life SMART drug plan

June 20, 2017

Great-West Life introduces the SMART drug plan In June 2017, Great-West Life is introducing the SMART drug plan, aiming for Sustainable,…

Posted by MORSE Team

pCPA Update as of May 31, 2017

June 14, 2017

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Updates The latest update as of May 31, 2017 has been issued by the pan-Canadian…

Posted by MORSE Team

Changes & Updates to CDR Guidelines June 9, 2017

June 12, 2017

Changes, Updates and Reminders Related to CDR Guidelines On Friday, June 9th, CADTH issued a CDR Update with a number of…

Posted by MORSE Team

New Drug Submission Guidelines in Quebec

June 8, 2017

INESSS Introduces New Pre-NOC and Biosimilar Guidance The Institut national d'excellence en santé et en services sociaux (INESSS) released its new…

Posted by MORSE Team

Upcoming Market Access Events / Conferences – June 2017

May 23, 2017

The MORSE KEY: Upcoming Events and Conferences There a number of conferences and events that individuals in market access may be interested…

Posted by MORSE Team

Federal Health Minister, Hon. Jane Philpott, Announces PMPRB Consultations

May 16, 2017

Consultations Commence for Major Changes to Canadian Pharmaceutical Policy On May 16, 2017, the Federal Minister of Health, the Hon. Jane…

Posted by MORSE Team

pCPA Update as of April 30, 2017

May 12, 2017

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The latest update as of April 30, 2017 has been issued by the pan-Canadian…

Posted by MORSE Team

MORSE Consulting Welcomes a Strategic Partner and a New Team Member!

May 1, 2017

Toronto, May 1, 2017 – Arvind Mani and Sherry O’Quinn are pleased to announce a strategic partnership with Brent Korte of Impact Consulting…

Posted by MORSE Team

Release of the ODB Program’s 2015/16 Annual Report Card

April 28, 2017

Ontario Update The Annual Report Card for the Ontario Drug Benefit Program for their 2015/16 fiscal year has been released. The…

Posted by MORSE Team

Upcoming Market Access Events / Conferences – May 2017

April 26, 2017

There a number of conferences and events that individuals in market access may be interested in for the upcoming month: Government/Agencies May…

Posted by MORSE Team

ODB Formulary Update – April 2017

April 21, 2017

Ontario Update The Ontario Drug Benefit (ODB) Formulary / Comparative Drug Index (Formulary) has been updated and becomes effective April 27,…

Posted by MORSE Team

Bridging the Gap Between Market Access and Internal Stakeholders [Infographic]

April 19, 2017

Publications, What's New

DKDA Consulting and MORSE Consulting have created an infographic which provides key tips to planning, preparing, and participating in market access advisory…

Posted by MORSE Team

pCPA Update as of March 31, 2017

April 12, 2017

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The latest update as of March 31, 2017 has been issued by the pan-Canadian…

Posted by MORSE Team

Introducing the MORSE KEY – a New Reimbursement Events Calendar

April 12, 2017

Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting Inc. is pleased to introduce a new feature on our website. The MORSE KEY…

Posted by MORSE Team

Market Access Advisory Board Meetings: Bridging the Gap Between Market Access and Internal Stakeholders

April 4, 2017

Dominika Dabrowski (DKDA Consulting), Arvind Mani (MORSE Consulting), and Sherry O’Quinn (MORSE Consulting) have collaborated on an article that describes best practices…

Posted by MORSE Team

pCPA Update as of February 28, 2017

March 16, 2017

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The pan-Canadian Pharmaceutical Alliance Office (pCPAO) updated the status of negotiations on brand name…

Posted by MORSE Team

Health Canada Guidance Document on the Disclosure of Confidential Business Information – March 10, 2017

March 10, 2017

Health Canada Update On March 10, 2017, Health Canada issued a guidance document which describes how it discloses confidential business information…

Posted by MORSE Team

The pan-Canadian Cancer Drug Funding Sustainability Initiative

March 8, 2017

CAPCA has initiated consultations with stakeholders on its recent initiative aimed at addressing the challenges facing the oncology drug system. The…

Posted by MORSE Team

Canada Attempts Biosimilar Balancing Act

March 2, 2017

Pink Sheet Pharma Intelligence published the attached article by Francesca Bruce on February 17, 2017. The article provides a helpful summary of…

Posted by MORSE Team

Terms of Reference for Scientific Advisory Panel on Opioid Use and Contraindications

February 28, 2017

Health Canada Update On February 24, 2017, Health Canada issued the Terms of Reference for the Scientific Advisory Panel on Opioid…

Posted by MORSE Team

BC Pharmacare Newsletter- February 2017

February 28, 2017

BC Update The British Columbia Pharmacare newsletter was published on February 27, 2017 See British Columbia's Newsletter As noted…

Posted by MORSE Team

Perspective on the pCPA Hepatitis C Negotiation

February 24, 2017

The pCPA has completed negotiations with 3 manufacturers of drugs used to treat Hepatitis C The pan-Canadian Pharmaceutical Alliance (pCPA), in…

Posted by MORSE Team

Alberta Drug Benefit List – March 2017

February 24, 2017

Alberta Update The Alberta Drug Benefit List (DBL) / Alberta Human Services Drug Benefit Supplement has been updated and becomes effective…

Posted by MORSE Team

ODB Formulary Update – February 2017

February 24, 2017

Ontario Update Ontario Drug Benefit (ODB) Formulary / Comparative Drug Index (Formulary) has been updated and becomes effective February 28, 2017.…

Posted by MORSE Team

The February 2017 Update for Quebec’s List of Medications

February 14, 2017

Quebec’s revised List of Medications has been posted, with Formulary changes effective as of February 15, 2017. For more information and to…

Posted by MORSE Team

PMPRB Releases its February 2017 Newsletter

February 13, 2017

The Patented Medicine Prices Review Board Provides an Update on its Activities The Patented Medicine Prices Review Board (PMPRB) released its…

Posted by MORSE Team

pCPA Update as of January 31, 2017

February 9, 2017

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The pan-Canadian Pharmaceutical Alliance Office (pCPAO) updated the status of negotiations on brand name…

Posted by MORSE Team

MORSE Perspective on pCPA Update as of December 31 2016

February 3, 2017

The pan-Canadian Pharmaceutical Alliance (pCPA) Office released the monthly statistics for pCPA negotiations up to and including December 31, 2016. To…

Posted by MORSE Team

New Consultancy Aims to “Decipher” Pharmaceutical Market Access

January 26, 2017

Mani & O’Quinn Reimbursement Strategy Experts (MORSE) launched to help clients develop strategies to optimize reimbursement success. Toronto, January 26, 2017…

Posted by MORSE Team